Tevogen Bio Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today issued a statement to provide clarity regarding its accumulated deficit reported under U.S. GAAP accounting standards in recent SEC filings. GAAP rules are designed for consistency and comparability across industries, but they can understate the value of high-growth biotechnolog ...